Skip to main content
Caplight Logo









Greenstone Biosciences

Greenstone Biosciences

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://greenstone.bio/

Last Round

Grant

May 15, 2024

Total Funding Raised

$27.26M

Company Overview

Greenstone Biosciences is a biotechnology company that operates a drug discovery platform integrating artificial intelligence, machine learning, and human-induced pluripotent stem cell (hiPSC) technology to accelerate the development of effective therapies.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug discoveryiPSCinduced pluripotent stem cellcomputational biologyAI-driven drug discoveryorganoid systemsADMET predictionpreclinical de-riskinghigh-throughput screeningAI biotechbiobankdisease modelingdigital biologyin silicoprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Greenstone Biosciences Comparables

Compare Greenstone Biosciences with similar companies based on industry and business-model similarity.

Greenstone Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vivodyne
88%
VALID Therapeutics
85%
Quris AI
84%

Greenstone Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 15, 2024
GrantApr 29, 2024
GrantSep 5, 2023
GrantDec 7, 2022
GrantOct 4, 2022
Seed
May 4, 2022

Greenstone Biosciences Investors

Notable investors and investment history

Greenstone Biosciences investors
InvestorRounds
NIH RADxGrant
A&E InvestmentsSeed
Walden CatalystSeed
California Institute for Regenerative MedicineGrant
Mayfield FundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors grew 228% MoM, reaching 28.6K.

Greenstone Biosciences Filings

Explore SEC and related filing metadata, where available.

Greenstone Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Greenstone Biosciences's valuation, stock price, and market status.

Is Greenstone Bio a public or private company?

Greenstone Bio is a private company.

What is the current stock price of Greenstone Bio?

Greenstone Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Greenstone Bio worth (valuation)?

Valuation information for Greenstone Bio is not publicly available.

Can I buy Greenstone Bio stock?

Greenstone Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Greenstone Bio's last funding round?

Greenstone Bio's most recent funding round was Grant on September 30, 2024.

Who are the main investors in Greenstone Bio?

Key investors in Greenstone Bio include Walden Catalyst.

Will Greenstone Bio IPO soon?

No public IPO plans have been announced for Greenstone Bio.

How can I track Greenstone Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Greenstone Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range18
Year Founded2021
Last FundingMay 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?